Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Press Release
Article
Camber Pharmaceuticals Launches Chlorzoxazone Tablets, USP
Key Takeaways
- Chlorzoxazone Tablets, USP, target relief from acute, painful musculoskeletal conditions as an adjunct therapy.
- The tablets are intended to complement rest, physical therapy, and other treatment measures.
Camber Pharmaceuticals is excited to announce the addition of Chlorzoxazone Tablets, USP.
Chlorzoxazone Tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
Chlorzoxazone 250 mg Tablets, USP are available in 60 count bottles.
To find out more information on Chlorzoxazone Tablets, USP, please visit: www.camberpharma.com/chlorzoxazone
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Videos
Related Content
